Clinical Trial Update: A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacokinetic of TQB3702 Tablets in Healthy Adult Subjects [Phase 1]

View source ↗

Summary

This Phase 1 trial evaluates the safety and pharmacokinetics of TQB3702 tablets in healthy adult subjects. The listed condition associated with the study is sys…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• TQB3702

Snippet

Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Conditions: Systemic Lupus Erythematosus | Phase 1 | Status: RECRUITING